therapeutic program (Rubedo Life Sciences/Cedars-Sinai Medical Center)

N/A

Report date: 2025/03/20 10:00:08
NME

Base Information

Drug Nametherapeutic program (Rubedo Life Sciences/Cedars-Sinai Medical Center)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRubedo Life Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesRubedo Life Sciences IncCedars-Sinai Medical Center
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A